We are live on
!
Find out more
BNP Paribas Asset Management Portfolio holdings
AUM
$86.1B
1-Year Est. Return
29.11%
This Fund
S&P 500
This Quarter
Est. Return
-2.17%
1 Year Est. Return
+29.11%
3 Year Est. Return
+87.64%
5 Year Est. Return
+102.48%
10 Year Est. Return
+408.22%
AUM
$86.1B
AUM Growth
-$1.05B
(-1.2%)
Cap. Flow
+$4.86B
Cap. Flow
% of AUM
5.64%
Top 10 Holdings %
Top 10 Hldgs %
27.63%
Holding
2,366
New
101
Increased
1,396
Reduced
686
Closed
108
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.43B |
| 2 |
TotalEnergies
TTE
|
+$626M |
| 3 |
Deutsche Bank
DB
|
+$326M |
| 4 |
Stellantis
STLA
|
+$263M |
| 5 |
Broadcom
AVGO
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ciena
CIEN
|
+$291M |
| 2 |
Apple
AAPL
|
+$262M |
| 3 |
Amazon
AMZN
|
+$219M |
| 4 |
Tesla
TSLA
|
+$205M |
| 5 |
Meta Platforms (Facebook)
META
|
+$197M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.22% |
| 2 | Healthcare | 13.97% |
| 3 | Financials | 10.51% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Krystal Biotech
KRYS
$9.55B
| $91.7K | ﹤0.01% |
355
+93
| +35% | +$24.7K |
|
1452
StoneX
SNEX
$8.07B
| $91.7K | ﹤0.01% |
1,706
+345
| +25% | +$17.4K |
|
|
NLOP
1453
Net Lease Office Properties
NLOP
$173M
| $91.6K | ﹤0.01% |
8,105
+2,140
| +36% | +$36K |
|
1454
Group 1 Automotive
GPI
$3.23B
| $91.6K | ﹤0.01% |
277
+78
| +39% | +$27.2K |
|
1455
Cactus
WHD
$5.5B
| $91.2K | ﹤0.01% |
1,925
+416
| +28% | +$21.8K |
|
1456
Chesapeake Utilities
CPK
$3.2B
| $91.1K | ﹤0.01% |
721
+221
| +44% | +$28.5K |
|
1457
Helmerich & Payne
HP
$3.7B
| $91.1K | ﹤0.01% |
2,528
+513
| +25% | +$17.5K |
|
1458
Lyft
LYFT
$6.19B
| $91.1K | ﹤0.01% |
6,848
+1,519
| +29% | +$23.5K |
|
|
PRMB
1459
Primo Brands
PRMB
$8.68B
| $90K | ﹤0.01% |
4,779
+1,262
| +36% | +$24.4K |
|
1460
Lazard
LAZ
$4.22B
| $89.9K | ﹤0.01% |
2,117
+553
| +35% | +$27.1K |
|
1461
Atlantic Union Bankshares
AUB
$6.02B
| $89.6K | ﹤0.01% |
+2,507
| New | +$94.4K |
|
1462
Bio-Rad Laboratories Class A
BIO
$9.16B
| $89.5K | ﹤0.01% |
321
+67
| +26% | +$19.3K |
|
|
KW
1463
DELISTED
Kennedy-Wilson Holdings
KW
| $89.3K | ﹤0.01% |
8,249
+1,018
| +14% | +$10.6K |
|
1464
Clearway Energy Class C
CWEN
$5.12B
| $89.2K | ﹤0.01% |
2,270
+199
| +10% | +$7.43K |
|
1465
Aurora
AUR
$13.3B
| $89.1K | ﹤0.01% |
21,634
+6,018
| +39% | +$26.6K |
|
1466
Box
BOX
$4.41B
| $89K | ﹤0.01% |
3,765
+1,345
| +56% | +$33.8K |
|
1467
First Bancorp
FBP
$4.44B
| $89K | ﹤0.01% |
4,165
+1,153
| +38% | +$24.8K |
|
1468
News Corp Class B
NWS
$18.3B
| $88.6K | ﹤0.01% |
3,107
-171
| -5% | -$4.82K |
|
1469
Franklin Electric
FELE
$4.83B
| $87.4K | ﹤0.01% |
948
+303
| +47% | +$29.7K |
|
|
KRMN
1470
Karman Holdings
KRMN
$7.31B
| $86.8K | ﹤0.01% |
1,084
-200,652
| -99% | -$19.4M |
|
1471
Merit Medical Systems
MMSI
$5.24B
| $86.4K | ﹤0.01% |
1,253
+357
| +40% | +$27.9K |
|
1472
Mirion Technologies
MIR
$3.74B
| $86.1K | ﹤0.01% |
4,634
+1,168
| +34% | +$26.3K |
|
1473
Louisiana-Pacific
LPX
$5.3B
| $85.9K | ﹤0.01% |
1,181
+282
| +31% | +$23.8K |
|
1474
White Mountains Insurance
WTM
$5.3B
| $85.7K | ﹤0.01% |
39
+7
| +22% | +$15K |
|
1475
Laureate Education
LAUR
$5.14B
| $85K | ﹤0.01% |
2,440
-4,046
| -62% | -$139K |
|
Similar funds
BNP Paribas Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, BNP Paribas Asset Management held 2,366 positions worth $86.1B, down 1.2% from $87.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
BNP Paribas Asset Management deployed $4.86B of net new capital in Q1 2026, opening 101 new positions and adding to 1,396 existing holdings. Its largest new stake was Viking Holdings: 1,864,036 shares worth $137M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Ciena, an estimated $291M trimmed.
- BNP Paribas Asset Management's largest Q1 2026 buy was Viking Holdings: 1,864,036 shares worth $137M.
- BNP Paribas Asset Management added most to AstraZeneca in Q1 2026, an estimated $1.43B increase.
- BNP Paribas Asset Management's biggest Q1 2026 reduction was Ciena, cutting an estimated $291M.
- BNP Paribas Asset Management fully exited Exact Sciences in Q1 2026, selling an estimated $35.9M.
- BNP Paribas Asset Management's ten largest holdings make up 28% of its $86.1B portfolio in Q1 2026.
- BNP Paribas Asset Management opened 101 new positions and closed 108 in Q1 2026.
- BNP Paribas Asset Management's portfolio value fell 1.2% quarter-over-quarter to $86.1B.
Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.